Earlier this year, the American Association for the Advancement of Science (AAAS) announced that John A. Blaho, Ph.D., Director of Industrial-Academic Research in the CUNY Central Office, was among the more than 500 scientists, engineers, and innovators elected 2022 Fellows of the AAAS for their scientifically and socially distinguished achievements throughout their careers.
John Blaho pictured with Sudip Parikh, AAAS CEO (left) and Keith Yamamoto, AAAS President (right)
at the AAAS Fellows Conference in Washington, DC, July 2023
Dr. Blaho was recognized in the Medical Sciences section for his “substantial advances in the field of virology and the development of innovative training programs for commercializing basic science research discoveries.” Dr. Blaho has received this lifetime AAAS Fellows honor for both his basic science and applied research careers at CUNY; he is the only CUNY AAAS Fellow in 2022.
AAAS is the world’s largest general scientific society and the publisher of the Science family of journals. AAAS was founded in 1848 and includes more than 250 affiliated societies and academies of science, serving 10 million individuals.
Dr. Blaho was first appointed to the doctoral faculty of CUNY in 1995 as a microbiology professor at the Mount Sinai School of Medicine, formerly affiliated with CUNY. He joined the CUNY Central Office in 2010 as its founding director for industrial-academic research. He is currently the program director of the New York I-Corps Hub based at CUNY, supported by the largest National Science Foundation award ever received by CUNY.
Dr. Blaho is also the principal investigator of the NYC Innovation Hot Spot, based in the CUNY Innovation and Applied Research Division, which the NYC Regional Economic Development Council of Empire State Development selected as a 2022 priority project.
Dr. Blaho recently co-authored with Dr. Stephanie Marrus of University of California San Francisco an article for Nature Biotechnology, “Increasing the success potential of promising biotech companies.” In it, they explore ways to help speed the process of bringing biotech discoveries to market, proposing a post I-Corps program modeled on the top academic and private sector accelerators that would be dedicated exclusively to I-Corps graduates.